# FDA Inspection 1249142 - LANXESS Corporation - September 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/lanxess-corporation/5864e1f8-ffec-40c3-9967-596db88b0aa7
Source feed: FDA_Inspections

> FDA Inspection 1249142 for LANXESS Corporation on September 12, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1249142
- Company Name: LANXESS Corporation
- Inspection Date: 2024-09-12
- Product Type: Human Drugs
- Office Name: Seattle District Office

## Related Documents

- [FDA Inspection 1249142 - 2024-09-12](https://www.keypedia.com/records/fda_inspections/lanxess-corporation/6dbe036d-939d-481d-92b7-5eeb98204b3c)
- [FDA Inspection 961641 - 2016-01-15](https://www.keypedia.com/records/fda_inspections/lanxess-corporation/1ee869f3-9bf9-4e73-907a-50e428024ad8)
- [FDA Inspection 858227 - 2013-12-05](https://www.keypedia.com/records/fda_inspections/lanxess-corporation/d1dbe404-f523-4331-8511-c03324fd9c21)
- [FDA Inspection 843254 - 2013-08-02](https://www.keypedia.com/records/fda_inspections/lanxess-corporation/ae74da48-4dc5-4769-8ad9-75093d952d8b)
- [FDA Inspection 637142 - 2009-12-17](https://www.keypedia.com/records/fda_inspections/lanxess-corporation/41a5cc4f-45fa-430f-b4be-264c3ec39199)

Company: https://www.keypedia.com/companies/lanxess-corporation/d4d93912-8e03-47f0-87e8-1aac96f0a44d

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913